Stock Markets Analysis & Opinion

MetLife, Inc. (NYSE:MET) is set to release fourth-quarter and full-year 2019 earnings on Feb 5.In the last reported quarter, the company’s earnings missed the Zacks Consensus Estimate by 9.93%...

Investors are always looking for stocks that are poised to beat at earnings season and Merck & Co., Inc. (NYSE:MRK) may be one such company. The firm has earnings coming up pretty soon, and...

Sony Corporation (NYSE:SNE) reported healthy third-quarter fiscal 2019 results, wherein adjusted earnings and revenues increased on a year-over-year basis.Net IncomeFor the fiscal third quarter,...

The key fourth-quarter technology stocks' earnings releases have painted a rosy picture so far, thanks to improving PC shipments, strengthening data center market, increasing proliferation of IoT and...

Tuesday, February 4, 2020An improvement in yesterday’s reported manufacturing data helped spur markets forward in regular trading, and market participants in today’s early morning trading...

NortonLifeLock, Inc. (NASDAQ:NLOK) is set to report third-quarter fiscal 2020 results on Feb 6.For the quarter, the company anticipates revenues between $602 million and $612 million (down 2% to...

Shares of Gilead Sciences, Inc. (NASDAQ:GILD) rose 5% after the company reported that its Remdesivir will undergo a trial for the CoronavirusShares of Maxar Technologies Inc. (TSX:MAXR) jumped...

We expect royalties from Innoviva, Inc.’s (NASDAQ:INVA) collaborated drugs to have driven revenues in fourth-quarter 2019.Shares of the company have lost 12.4% in the past...

Hexcel Corporation (NYSE:HXL) reported fourth-quarter 2019 adjusted earnings of 86 cents per share, surpassing the Zacks Consensus Estimate of 85 cents by 1.2%. Further, the bottom line improved...

Electronics stocks' quarterly results reflect growing adoption of AR/VR devices, AI, ML and cloud computing. Further, IoT supported industrial automation and rising demand for connected appliances in...

Check Point Software Technologies Ltd. (NASDAQ:CHKP) reported fourth-quarter 2019 results, wherein the bottom line beat and the top line came in line with the Zacks Consensus Estimate.The...

Bristol-Myers’ (NYSE:BMY) immuno-oncology drug, Opdivo, which is approved for multiple oncology indications, fueled the top line in the third quarter of 2019. The uptake of the drug continued...

Sanderson Farms, Inc. (NASDAQ:SAFM) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some...

Retail Value Inc. (NYSE:RVI) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope...